Ping Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$265K Buy
7,000
+2,000
+40% +$92.2K 0.05% 80
2026
Q2
$240K Buy
+5,000
New +$215K 0.06% 88

Other funds holding NVO

Ping Capital Management's NVO Position: Q3 2026 in Review

Ping Capital Management increased its Novo Nordisk (NVO) stake by 40% in Q3 2026, buying an estimated $92.2K and bringing the position to 7,000 shares worth $265K. The position accounts for 0.05% of the portfolio, ranked #80.

Ping Capital Management first reported a position in NVO in Q2 2026 and has held it in 2 quarters since. 994 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Ping Capital Management held 7,000 shares of Novo Nordisk worth $265K as of Q3 2026.
  • Ping Capital Management bought 2,000 Novo Nordisk shares in Q3 2026, an estimated $92.2K.
  • Novo Nordisk made up 0.05% of Ping Capital Management's portfolio in Q3 2026, its #80 holding.
  • Ping Capital Management first reported a position in Novo Nordisk in Q2 2026 and has held it in 2 quarters since.
  • 994 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Ping Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.